Experiences with the use of GLP-1 receptor agonist regarding weight loss as a primary outcome in PCOS are still very limited although an essential role of GLP-1 as a multi-targeting regulator of food intake has been recognized also in this population [6]. Here, GLP1R is linked to polycystic ovary syndrome.